Connect Biopharma Limite...

NASDAQ: CNTB · Real-Time Price · USD
2.03
-0.12 (-5.58%)
At close: Aug 15, 2025, 3:59 PM
2.09
2.96%
After-hours: Aug 15, 2025, 05:23 PM EDT

Connect Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Cash & Equivalents
78.23M 110.17M 106.01M 81.39M 80.37M 141.56M 268.02M 313.13M
Short-Term Investments
15.48M 67K 12.65M 49.82M 74.67M 49.34M n/a n/a
Long-Term Investments
n/a n/a n/a n/a 9.6M 22.33M n/a n/a
Other Long-Term Assets
33K 96K 132K 735.53K 34.62K 72.36K 2.9M 2.06M
Receivables
1.05M 3.85M n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a -13.95M 3.48M 3.18M 6.7M n/a n/a
Other Current Assets
53K n/a n/a 3.1M n/a 1.11M n/a 1.13M
Total Current Assets
96.96M 115.9M 120.97M 137.81M 158.46M 198.04M 275.44M 324.4M
Property-Plant & Equipment
4.24M 4.52M 4.73M 5.09M 5.47M 10.76M 9.5M 6.18M
Goodwill & Intangibles
53K 57K 62K 64.59K 3.22M 3.33M 3.54M 3.48M
Total Long-Term Assets
4.32M 4.67M 4.92M 5.89M 18.55M 36.98M 15.94M 11.72M
Total Assets
101.28M 120.57M 125.89M 143.7M 177.01M 235.02M 291.39M 336.12M
Account Payables
342K 5.7M 7.66M 11.46M 11.94M 15.18M 12.73M 10.16M
Deferred Revenue
164K n/a 13.32M n/a n/a n/a n/a n/a
Short-Term Debt
154K n/a n/a n/a n/a n/a n/a 95.1K
Other Current Liabilities
95K 1.71M 13.76M 2.46M 2.69M 3.76M 5.15M 3.39M
Total Current Liabilities
8.46M 9.62M 24.26M 14.89M 15.89M 20.68M 18.01M 14.01M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a 74.53K
Other Long-Term Liabilities
632K n/a n/a 161.64K n/a 286.00 784K -74.53K
Total Long-Term Liabilities
656K 467K 585K 483.64K 911.83K 1.05M 810.73K 74.53K
Total Liabilities
9.12M 10.09M 24.85M 15.37M 16.81M 21.73M 18.82M 14.09M
Total Debt
178K 325K 465K 592.68K 437.88K 561.91K 124.52K 169.63K
Common Stock
10K 10K 10K 9.11K 9.64K 9.85K 10.36K 10.21K
Retained Earnings
-345.36M -531.7M -539.35M -467.52M -463.76M -414.71M -373.43M -311.39M
Comprehensive Income
-1.67M 13.48M -7.88M 13.76M 10.39M 3.85M -6.48M -3.17M
Shareholders Equity
92.17M 110.48M 101.04M 128.32M 160.21M 213.29M 272.57M 322.03M
Total Investments
15.48M 67K 12.65M 49.82M 84.27M 71.67M n/a n/a